Detalles de la búsqueda
1.
Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer's Disease Hallmarks.
Int J Mol Sci
; 25(5)2024 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473843
2.
Inhibition of Soluble Epoxide Hydrolase Ameliorates Phenotype and Cognitive Abilities in a Murine Model of Niemann Pick Type C Disease.
Int J Mol Sci
; 22(7)2021 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33810307
3.
Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics.
CNS Neurosci Ther
; 30(4): e14511, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37905690
4.
A Combined Chronic Low-Dose Soluble Epoxide Hydrolase and Acetylcholinesterase Pharmacological Inhibition Promotes Memory Reinstatement in Alzheimer's Disease Mice Models.
Pharmaceuticals (Basel)
; 15(8)2022 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35893732
5.
Cognitive Decline and BPSD Are Concomitant with Autophagic and Synaptic Deficits Associated with G9a Alterations in Aged SAMP8 Mice.
Cells
; 11(16)2022 08 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36010679
6.
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
J Med Chem
; 65(6): 4909-4925, 2022 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35271276
Resultados
1 -
6
de 6
1
Próxima >
>>